| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| curcumin | multidrug resistance-associated protein 5 | small molecule | NA | drugbank | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
NA | approved,investigational | inhibitor |
| curcumin | amyloid beta a4 protein | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.12 | phase 3 | unknown |
| curcumin | carbonic anhydrase i | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.03 | phase 3 | unknown |
| curcumin | carbonic anhydrase xii | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.07 | phase 3 | unknown |
| curcumin | carbonic anhydrase xiv | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.07 | phase 3 | unknown |
| curcumin | carbonic anhydrase ii | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.04 | phase 3 | unknown |
| curcumin | carbonic anhydrase iv | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.06 | phase 3 | unknown |
| curcumin | carbonic anhydrase vi | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.18 | phase 3 | unknown |
| curcumin | carbonic anhydrase ix | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.08 | phase 3 | unknown |
| curcumin | carbonyl reductase [nadph] 1 | small molecule | NA | drugbank | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
NA | approved,investigational | unknown |
| curcumin | albendazole monooxygenase | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0 | phase 3 | unknown |
| curcumin | dna [cytosine-5]-methyltransferase 3b | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.9 | phase 3 | unknown |
| curcumin | glutathione s-transferase p | small molecule | NA | drugbank , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.06 | approved,investigational | unknown |
| curcumin | matrix metalloproteinase-13 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.13 | phase 3 | unknown |
| curcumin | matrix metalloproteinase-9 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.06 | phase 3 | unknown |
| curcumin | nitric-oxide synthase inducible | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.04 | phase 3 | unknown |
| curcumin | peroxisome proliferator-activated receptor gamma | small molecule | NA | drugbank | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
NA | approved,investigational | unknown |
| curcumin | prostaglandin g/h synthase 1 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.04 | phase 3 | unknown |
| curcumin | prostaglandin g/h synthase 2 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.03 | phase 3 | unknown |
| curcumin | vitamin d3 receptor | small molecule | NA | drugbank , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.01 | approved,investigational | unknown |
| curcumin | xanthine dehydrogenase/oxidase | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.04 | phase 3 | unknown |
| click here to return to the previous page | ||||||||